Overview

  • Product name
    Vecuronium bromide
  • Description
    Competitive nicotinic acetylcholine receptor (nAChR) antagonist
  • Biological description
    Competitive nicotinic acetylcholine receptor (nAChR) antagonist (IC50 = 9.9 nM). Muscle relaxant. Inhibits neural response to hypoxia.

Properties

References

This product has been referenced in:
  • Liu M & Dilger JP Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor. Mol Pharmacol 75:166-73 (2009). Read more (PubMed: 18842832) »
  • Dilger JP  et al. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists. Anesthesiology 106:1186-95 (2007). Read more (PubMed: 17525594) »
  • Igarashi A  et al. Vecuronium directly inhibits hypoxic neurotransmission of the rat carotid body. Anesth Analg 94:117-22, table of contents (2002). Read more (PubMed: 11772812) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120536.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up